Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 291 of the 291 references it cites were found in a registry or an index; 57 of the 310 sources its claims cite were checked for support.

Bone remodeling: an operational process ensuring survival and bone mechanical competence

Open access

Abstract

Bone remodeling replaces old and damaged bone with new bone through a sequence of cellular events occurring on the same surface without any change in bone shape. It was initially thought that the basic multicellular unit (BMU) responsible for bone remodeling consists of osteoclasts and osteoblasts functioning through a hierarchical sequence of events organized into distinct stages. However, recent discoveries have indicated that all bone cells participate in BMU formation by interacting both simultaneously and at different differentiation stages with their progenitors, other cells, and bone matrix constituents. Therefore, bone remodeling is currently considered a physiological outcome of continuous cellular operational processes optimized to confer a survival advantage. Bone remodeling defines the primary activities that BMUs need to perform to renew successfully bone structural units. Hence, this review summarizes the current understanding of bone remodeling and future research directions with the aim of providing a clinically relevant biological background with which to identify targets for therapeutic strategies in osteoporosis.

Overview

CoChat Summary

TL;DR

This review reframes bone remodeling as a continuous, integrated operational process executed by basic multicellular units (BMUs), rather than a strict sequence of discrete stages, with osteocytes, osteoclasts, osteoblasts, lining/canopy cells, reversal cells, and osteomorphs all contributing. It synthesizes mechanotransduction, RANKL/RANK/OPG signaling, coupling factors, and intermediate cell phenotypes to identify therapeutic targets in osteoporosis.

Key findings

  • Bone remodeling is a continuous flow of connected cellular events, not discrete stages; the BMU includes all bone cells at all differentiation stages, and focal coupling is asynchronous, producing a transient “virtual space” of bone loss. The BMU endures longer (9 months) than the lifespan of each single component.
  • Osteocytes are master coordinators: they represent more than 90% of adult bone cells, with an estimated 19,000–28,500 cells per mm³ (~42 billion cells) and 23 trillion connections; Frost estimated an osteocyte lifespan of ~25 years, and 9.1 million osteocytes are replaced daily. They sense fluid flow shear stress via collagen hillocks, integrins, primary cilia, connexin43, and Piezo1, and regulate RANKL/OPG/SOST.
  • Osteoclasts can be “anabolic” independent of resorption: in osteoclast-rich osteopetrosis and with odanacatib, bone formation is maintained or enhanced despite impaired resorption. Osteoclast-derived factors (CT-1, S1P, Wnt10B, BMP6, CTHRC1, C3a, LIF, SLIT3, DPP4) and extracellular vesicles (25–120 nm) carrying RANK can promote osteogenesis via reverse signaling.
  • Intermediate phenotypes tune coupling: active osteoblasts have an average lifespan of 3 months; 60%–80% die by apoptosis and 5%–20% become osteocytes. Reversal cells colonize eroded surfaces covering 80% of them, and osteomorph recycling helps explain denosumab discontinuation rebound.

Methods

  • Narrative review: the authors describe, update, and reexamine current evidence and biological plausibility for bone remodeling, explicitly presenting it as a continuous flow rather than staged process.
  • No systematic search strategy, databases, inclusion/exclusion criteria, or primary data collection are reported; the synthesis draws on cited animal models, human biopsy/imaging studies, and clinical trials.
  • Main analysis is conceptual integration of cellular and molecular mechanisms, including BMU structure, osteocyte mechanosensing, osteoclast–osteoblast coupling, and therapeutic implications.

Limitations

  • The paper states several unresolved issues: the exact in vivo form and localization of osteocyte RANKL; how the bone remodeling compartment forms; whether osteoclast-derived coupling factors act similarly in humans; the mechanism controlling apoptotic body delivery within each BMU; the role of 1,25(OH)₂D₃ in osteocyte metabolism; how osteocytes sense phosphate; and the efficiency of perilacunar remodeling in calcium homeostasis.
  • Evident from the text: as a narrative review, it lacks systematic search and quality appraisal, relies on heterogeneous preclinical and clinical evidence, and includes speculative or hypothetical mechanisms (e.g., “might,” “hypothesized”) without new primary data.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/s41413-022-00219-8

Cites

291 of 291 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 The cutting cone. The cutting cone originates in close proximity to neurovascular axial bundles and is generated by the propagation of the basic multicellular unit (BMU). The cutting cone consists of a set of osteoclasts, followed by a set of osteoblasts, reversal cells and secondary osteoclasts that cover the so-called reversal zone. At the end of the reversal zone, a set of osteocytes generate the closing zone. A line of symmetry divides in half the representation of a complete BMU in the cortex moving toward the longitudinal axis of the long bone. One-half of cortical BMU is similar to the BMU at the cancellous surface, although in cancellous bone, the BMU is separated from the marrow by a specific cell structure called the canopy
Fig. 1 The cutting cone. The cutting cone originates in close proximity to neurovascular axial bundles and is generated by the propagation of the basic multicellular unit (BMU). The cutting cone consists of a set of osteoclasts, followed by a set of osteoblasts, reversal cells and secondary osteoclasts that cover the so-called reversal zone. At the end of the reversal zone, a set of osteocytes generate the closing zone. A line of symmetry divides in half the representation of a complete BMU in the cortex moving toward the longitudinal axis of the long bone. One-half of cortical BMU is similar to the BMU at the cancellous surface, although in cancellous bone, the BMU is separated from the marrow by a specific cell structure called the canopyCC BY · PubMed Central
Fig. 2 The “find me” message from apoptotic osteocytes. Under fatigue failure, osteocytes undergo apoptosis, whereas the osteocytes surrounding the apoptotic osteocytes, the “bystander osteocytes”, show upregulation of the antiapoptotic protein BcL-2, which protects them from death. Apoptotic osteocytes activate the Panx1/P2XR pathway to induce the release of ATP into the extracellular compartment as a specific “find me” signal. ATP binds P2Y2 receptors on bystander osteocytes, which in turn produce and release RANKL at the interface with the bone marrow. RANKL promotes the recruitment of osteoclast progenitors and osteoclastogenesis
Fig. 2 The “find me” message from apoptotic osteocytes. Under fatigue failure, osteocytes undergo apoptosis, whereas the osteocytes surrounding the apoptotic osteocytes, the “bystander osteocytes”, show upregulation of the antiapoptotic protein BcL-2, which protects them from death. Apoptotic osteocytes activate the Panx1/P2XR pathway to induce the release of ATP into the extracellular compartment as a specific “find me” signal. ATP binds P2Y2 receptors on bystander osteocytes, which in turn produce and release RANKL at the interface with the bone marrow. RANKL promotes the recruitment of osteoclast progenitors and osteoclastogenesisCC BY · PubMed Central
Fig. 3 The bone remodeling compartment (BRC). a The BRC provides the correct microenvironment to link bone formation and resorption through local signaling. The bone marrow envelope (BME) is a layer of cells of mesenchymal origin and a reservoir for osteoprogenitors that covers the layer of bone lining cells (BLCs). Once remodeling is initiated, osteoclasts lift the BME from the BLC, inducing BME cells to form a structure called the canopy. The canopy separates the remodeling site from the remainder of the bone marrow to allow osteoclast and osteoblast precursors to enter the blood compartment. After resorption, osteoclasts either undergo apoptosis or dedifferentiate into osteomorphs. The resorbed surface is then colonized by secondary osteoclasts and reversal cells. Reversal cells are osteoblast progenitors that digest fibrillar collagen remnants, similar to BLCs. Secondary osteoclasts and reversal cells provide the basis for the recruitment and expansion of osteoblastic pools (b) except under certain counteracting conditions, such as glucocorticoid or alendronate treatment, myeloma, or postmenopausal osteoporosis
Fig. 3 The bone remodeling compartment (BRC). a The BRC provides the correct microenvironment to link bone formation and resorption through local signaling. The bone marrow envelope (BME) is a layer of cells of mesenchymal origin and a reservoir for osteoprogenitors that covers the layer of bone lining cells (BLCs). Once remodeling is initiated, osteoclasts lift the BME from the BLC, inducing BME cells to form a structure called the canopy. The canopy separates the remodeling site from the remainder of the bone marrow to allow osteoclast and osteoblast precursors to enter the blood compartment. After resorption, osteoclasts either undergo apoptosis or dedifferentiate into osteomorphs. The resorbed surface is then colonized by secondary osteoclasts and reversal cells. Reversal cells are osteoblast progenitors that digest fibrillar collagen remnants, similar to BLCs. Secondary osteoclasts and reversal cells provide the basis for the recruitment and expansion of osteoblastic pools (b) except under certain counteracting conditions, such as glucocorticoid or alendronate treatment, myeloma, or postmenopausal osteoporosisCC BY · PubMed Central
Fig. 4 Released extracellular matrix (ECM) factors. Two major factors are released by the ECM upon bone resorption and cooperate to regulate bone remodeling and BMU activity: TGF-β1 and IGF-1. After release from the matrix, active TGF-β1 acts both on osteoblasts and osteoclasts to induce osteoblast precursor migration to the site of resorption and osteoclast production of Wnt1, which promotes osteoblast recruitment and/or differentiation at sites of bone resorption, and Wint10b, which promotes matrix mineralization. IGF-1 supports the recruitment of osteoblast progenitors and promotes osteoblast differentiation and matrix mineralization by inducing the transcription of osteogenesis‐related genes such as DMP1, PHEX, SOST, BMP2, RUNX2, OPN, and OCN
Fig. 4 Released extracellular matrix (ECM) factors. Two major factors are released by the ECM upon bone resorption and cooperate to regulate bone remodeling and BMU activity: TGF-β1 and IGF-1. After release from the matrix, active TGF-β1 acts both on osteoblasts and osteoclasts to induce osteoblast precursor migration to the site of resorption and osteoclast production of Wnt1, which promotes osteoblast recruitment and/or differentiation at sites of bone resorption, and Wint10b, which promotes matrix mineralization. IGF-1 supports the recruitment of osteoblast progenitors and promotes osteoblast differentiation and matrix mineralization by inducing the transcription of osteogenesis‐related genes such as DMP1, PHEX, SOST, BMP2, RUNX2, OPN, and OCNCC BY · PubMed Central
Fig. 5 Anabolic osteoclasts. Osteoblasts stimulate osteoclastogenesis by producing RANKL as a forward signal. However, osteoclasts can act as anabolic cells by generating positive reverse signaling in osteoblasts. Both resorbing and apoptotic osteoclasts can release extracellular vesicles (EVs) that contain RANK. Once discharged from EVs, RANK binds RANKL clusters on the osteoblast membrane and activates osteogenesis via the mTOR pathway. In addition, EphrinB2 signaling from osteoclasts to EphB4 on osteoblasts/bone lining cells (BLCs)/reversal cells favors osteogenic differentiation
Fig. 5 Anabolic osteoclasts. Osteoblasts stimulate osteoclastogenesis by producing RANKL as a forward signal. However, osteoclasts can act as anabolic cells by generating positive reverse signaling in osteoblasts. Both resorbing and apoptotic osteoclasts can release extracellular vesicles (EVs) that contain RANK. Once discharged from EVs, RANK binds RANKL clusters on the osteoblast membrane and activates osteogenesis via the mTOR pathway. In addition, EphrinB2 signaling from osteoclasts to EphB4 on osteoblasts/bone lining cells (BLCs)/reversal cells favors osteogenic differentiationCC BY · PubMed Central

Verification

Claims the paper makes

42 Valid · 4 Not valid · 201 Not checked · 72 Own results and interpretations

160 more claims · 24 with their cited sources checked

Create a free account to see all 319 claims and to verify the 253 references still open.

See all claims — free account
  • It may state two separate claims as one. 129
  • Probably not a substantial claim. 33
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 291 references

Research works printed but not linked: 3

  1. Bonewald, L. F. & Marcus, D. F. R. In Osteoporosis 3rd edn (eds Nelson, D. & Rosen, C.) 170–189 (Elsevier, 2008).
  2. Baron, R., Vignery, A. & Van Tran, P. The significance of lacunar erosion without osteoclasts: studies on the reversal phase of the remodeling sequence. Metab. Bone Dis. Relat. Res. 2, 35–40 (1980).
  3. Marotti, G., Ferretti, M., Palumbo, C. & Benincasa, M. Static anddynamic bone formation and the mechanism of collagen fiberorientation. Bone 25, 156 (1999).

Cited by

See all 482

Metadata

Authors
Bolamperti, S., Villa, I., & Rubinacci, A.
Affiliations
IRCCS Ospedale San Raffaele (IT)
Corresponding author
Rubinacci, Alessandro
Venue
Bone Research
Published
2022-07-18
Volume
10
Issue
1
Pages
48-48
ISSN
  • 2095-4700 (ISSN-L)
  • 2095-6231
OpenAlex
W4285729461
Cited by
482
References
291
Citations by year
2026: 137 · 2025: 161 · 2024: 112 · 2023: 64 · 2022: 8
FWCI
8.97
Type
journal article
Language
en
Open access
Licence
Locations
  • Bone Research (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Alkaline Phosphatase Research Studies
Keywords
bone remodeling, basic multicellular unit, osteoclasts, osteoblasts, bone cells, bone matrix, osteoporosis, therapeutic target

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-09-30, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-09-30 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Bone remodeling: an operational process ensuring survival and bone mechanical competence. https://app.cochat.ai/papers/10.1038/s41413-022-00219-8
The paper
Bolamperti, S., Villa, I., & Rubinacci, A. (2022). Bone remodeling: an operational process ensuring survival and bone mechanical competence. Bone Research. https://doi.org/10.1038/s41413-022-00219-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.